Sanctuary Advisors’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.09M Sell
10,253
-13,716
-57% -$1.66M 0.01% 1384
2026
Q1
$3.92M Buy
23,969
+2,633
+12% +$405K 0.02% 636
2025
Q4
$3.71M Buy
21,336
+1,802
+9% +$329K 0.02% 642
2025
Q3
$2.81M Buy
19,534
+8,443
+76% +$1.03M 0.02% 735
2025
Q2
$1.12M Buy
11,091
+7,201
+185% +$551K 0.01% 1153
2025
Q1
$297K Buy
3,890
+29
+0.8% +$2.22K ﹤0.01% 1803
2024
Q4
$295K Buy
3,861
+464
+14% +$33.4K ﹤0.01% 2008
2024
Q3
$248K Buy
+3,397
New +$251K ﹤0.01% 2114

Other funds holding INSM

Sanctuary Advisors's INSM Position: Q2 2026 in Review

Sanctuary Advisors reduced its Insmed (INSM) stake by 57% in Q2 2026, selling an estimated $1.66M and leaving 10,253 shares worth $1.09M. The position accounts for 0.01% of the portfolio, ranked #1384.

Sanctuary Advisors first reported a position in INSM in Q3 2024 and has held it in 8 quarters since. The position peaked at $3.92M in Q1 2026. 665 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Sanctuary Advisors held 10,253 shares of Insmed worth $1.09M as of Q2 2026.
  • Sanctuary Advisors sold 13,716 Insmed shares in Q2 2026, an estimated $1.66M.
  • Insmed made up 0.01% of Sanctuary Advisors's portfolio in Q2 2026, its #1384 holding.
  • Sanctuary Advisors first reported a position in Insmed in Q3 2024 and has held it in 8 quarters since.
  • Sanctuary Advisors's Insmed position peaked at $3.92M in Q1 2026.
  • 665 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Sanctuary Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.